Top Markets
#1 Helium Helium +60.93%
#2 GEKKO GEKKO +48.56%
#3 Pons Pons +41.70%
#4 ADO Protocol ADO Protocol +39.04%
#5 Prom Prom +37.33%
#6 TENDIES TENDIES +31.81%
#7 StonkBroker StonkBroker +30.27%
#8 Collector Crypt Collector Crypt +29.05%
#9 Collect on Fanable Collect on Fanable +23.84%
#10 龙虾 (Lobster) 龙虾 (Lobster) +21.43%
Coin of the day
Helium Helium
Settings
Language
ENGLISH
Currency
USD
Theme
MedCap AB (publ) MedCap AB (publ)

MedCap AB (publ)

MCAP
Rank in Stocks #9767
MedCap AB (publ) operates as a private equity firm, employing a diverse array... MedCap AB (publ) operates as a private equity firm, employing a diverse array of investment strategies including secondary direct deals, later-stage funding, industry consolidation, growth capital provision, engagement with middle-market and mature businesses, turnarounds, and outright buyouts. The company primarily directs its capital towards businesses within the healthcare sector, focusing on medical equipment and services, biotechnology, life sciences, and pharmaceuticals. It actively seeks unlisted, small to mid-sized companies located predominantly across Northern Europe. Equity investments typically fall within the SEK 25 million to SEK 150 million range (approximately $2.75 million to $16.51 million). Target companies generally exhibit an enterprise value and annual sales revenue between SEK 50 million and SEK 200 million ($5.90 million to $23.06 million), alongside an EBITDA of SEK 1 million to SEK 50 million ($0.11 million to $5.50 million). MedCap aims to acquire ownership stakes of 20% to 50% in its portfolio entities, financing these through its own capital, loans, and direct balance sheet investments. Established in 2001, the firm maintains its headquarters in Stockholm, Sweden.
Share Price
$63.50
Last synced: 2026-08-28
Market Cap
$950.92M
Change (1 day)
3.27%
Change (1 year)
-2.15%
Country
SE
Trade MedCap AB (publ) (MCAP)

Category

Healthcare
P/E ratio for MedCap AB (publ) (MCAP)
P/E ratio as of 2026 TTM: 0
According to MedCap AB (publ) latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for MedCap AB (publ) from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
BlackRock, Inc. BlackRock, Inc.
BlackRock, Inc.
BLK.US
 27.69 -
US
Blackstone Inc. Blackstone Inc.
Blackstone Inc.
BX.US
 31.99 -
US
Investor AB (publ) Investor AB (publ)
Investor AB (publ)
INVE-A.ST
 - -
SE
KKR & Co. Inc. KKR & Co. Inc.
KKR & Co. Inc.
KKR.US
 33.93 -
US
Brookfield Asset Management Ltd. Brookfield Asset Management Ltd.
Brookfield Asset Management Ltd.
BAM.US
 31.21 -
US
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.